Table 3. Binary logistic regression analysis of sociodemographic and clinical variables as predictors of the use of CAM therapy in IBD patients.

*P-value statistically significant

CAM: complementary and alternative medicine; IBD: inflammatory bowel disease; TNF: tumor necrosis factor

Variable	Odds ratio	95% confidence interval		P-value
		Lower	Upper
Gender	2.1	0.49	8.9	0.32
Marital status	1.6	0.29	8.5	0.58
Education	1.5	0.34	6.8	0.59
Monthly income	4.2	0.39	44	0.23
Smoking	1.9	0.21	17.7	0.57
IBD types	0.92	0.14	6	0.93
Abdominal pain	0.56	0.05	6.5	0.64
Watery diarrhea	5.7	1	31	0.046*
Nausea and vomiting	1.1	0.19	5.6	0.95
Rectal bleeding	1.8	0.36	8.9	0.48
Corticosteroids	2.5	0.33	18.9	0.38
Azathioprine	18.1	1.3	255	0.03*
Anti-TNF-alpha therapy	2	0.37	11.4	0.41